An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients
NCT ID: NCT03722264
Last Updated: 2020-03-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2017-11-16
2019-04-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Randomized Controlled Trial for Prevention of Demineralization During Fixed Orthodontic Treatment
NCT04342858
Orthodontic Varnish Microbiology Study
NCT04528134
Prevention of Enamel Demineralization Using CPP-ACP-NaF Varnish
NCT04002232
The Effect of Different Remineralizing Agents on White Spot Lesions and Dental Plaque During Orthodontic Retention
NCT04788550
Comparing Fluoride Varnish and Sealant to Prevent White Spots in Orthodontic Patients
NCT04560478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Orthodontic patients are at particular risk of developing two types of early carious lesions (decay):
1. Around the brackets called White Spot Lesions and
2. Along the sides of the teeth after slenderization procedure called inter-proximal reduction (IPR).
Our research questions are:
1. Can OpalSeal offer protection against white spot lesions (WSL) around the brackets?
2. Can OpalSeal offer protection against decay on the sides of teeth following IPR?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
DOUBLE
The outcomes assessor will also be blinded to the groups assignments.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OpalSeal
OpalSeal will be applied
1. to the buccal surfaces of to-be-extracted teeth on one side of the mouth which will be determined randomly for each participant during bonding of orthodontic brackets, or
2. to the proximal surfaces following IPR in accordance to manufacturer instructions. Since OpalSeal has fluoride releasing capability, this would be experimental arm
OpalSeal
OpalSeal is a fluoride releasing orthodontic primer that is FDA approved for use during bonding of orthodontic brackets
Transbond XT
TransbondXT will be applied
1. to the buccal surfaces of to-be-extracted teeth on the other side of the mouth which will be determined based on which side received OpalSeal for each participant during bonding of orthodontic brackets, or
2. to the proximal surfaces following IPR in accordance to manufacturer instructions. Transbond XT does not have fluoride and hence would be considered as a placebo.
TransbondXT
Transbond is a primer used to bond orthodontic brackets that does not contain fluoride
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OpalSeal
OpalSeal is a fluoride releasing orthodontic primer that is FDA approved for use during bonding of orthodontic brackets
TransbondXT
Transbond is a primer used to bond orthodontic brackets that does not contain fluoride
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Such teeth should be free of any developmental defects
Exclusion Criteria
* Patients with defective teeth
* Those who cannot provide consent/assent OR not able to follow research protocols
* Protected population (prisoners)
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Parthasarathy Madurantakam, DDS
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Dentistry, Virginia Commonwealth University
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HM20011025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.